Quantoom Biosciences

Gold Sponsor

Quantoom Biosciences is leading the revolution in mRNA-based vaccines by offering turnkey solutions for mRNA-LNP manufacturing. Its cutting-edge Ntensify™ technology enables the production and purification of mRNA through a fully integrated, scalable system that combines processes, equipment, reagent mixes, and disposables. This solution supports the entire spectrum of mRNA production, from R&D to commercial manufacturing. Launched in 2023, Ntensify™ has already been widely adopted across multiple continents, showcasing its global appeal. Quantoom Biosciences is also developing the Ncapsulate™ technology for mRNA-LNP formulation and purification, aiming to significantly increase the accessibility and affordability of mRNA-based vaccines. Located in Belgium, Quantoom Biosciences thrives in a dynamic biotech ecosystem, driving innovation in mRNA production to make life-changing therapies available to everyone, everywhere.
For more information, visit www.quantoom.com.